Please login to the form below

Not currently logged in
Email:
Password:

real world evidence

This page shows the latest real world evidence news and features for those working in and with pharma, biotech and healthcare.

NHS England wants money-back guarantee on Orkambi

NHS England wants money-back guarantee on Orkambi

Vertex resisting real-world data proposal. NHS England and Vertex are both claiming to have made significant new concessions in order to break the deadlock over cystic fibrosis drug Orkambi– but ... This would involve the collection of real-world data

Latest news

More from news
Approximately 11 fully matching, plus 74 partially matching documents found.

Latest Intelligence

  • Is it time for a more integrated and human-centric approach to Medical Affairs leadership? Is it time for a more integrated and human-centric approach to Medical Affairs leadership?

    lead the communication of increasingly complex science and the implementation of trials that yield real-world evidence (RWE) to demonstrate clinical value. ... to create a single voice with which to speak to the external world; a voice that must remain

  • The UK’s new medicines pricing deal – opportunities and risks for pharma The UK’s new medicines pricing deal – opportunities and risks for pharma

    The ambition is for more ‘real-world evidence’, which could be included on an indication-specific basis. ... This is further evidence of the influence of NHSE. New incentives to greater cost-effectiveness.

  • #OrkambiNow? #OrkambiNow?

    The answer is likely to lie, at least in part, in exploiting the UK’s CF disease registry to provide real-world evidence of the drugs’ effectiveness. ... It is also notable that the Cystic Fibrosis Trust’s suggestion of allowing interim access and

  • “Brexit has been a catalyst for UK clinical research... it’s turbocharged change” “Brexit has been a catalyst for UK clinical research... it’s turbocharged change”

    The partnership will aim to enable faster and more efficient drug research, generate more robust evidence to support treatment value, and ultimately provide greater access to personalised medicines. ... and real-world evidence studies.

  • Launch trends 2019 Launch trends 2019

    A key trend is increasing evidence needs, ie, having greater evidence to ensure reimbursement of high prices, even for orphan drugs. ... Market access is becoming more complex, with new requirements such as real-world evidence (RWE), conditional

More from intelligence
Approximately 8 fully matching, plus 50 partially matching documents found.

Latest appointments

  • Remi Gauchoux joins Carenity Remi Gauchoux joins Carenity

    Gauchoux has a 20-year international experience in healthcare and the CRO industries with expertise in late phase and real-world evidence analysis.

  • Dr Ameet Nathwani moves from Novartis to Sanofi Dr Ameet Nathwani moves from Novartis to Sanofi

    Oliver Brandicourt, Sanofi's chief executive officer, said: “Our industry is experiencing increased pressure to support reimbursement with customized data from real-world evidence, demonstrate ongoing benefit-risk of registered products

  • EMA's Dr Stella Blackburn joins Quintiles EMA's Dr Stella Blackburn joins Quintiles

    Cynthia Verst, president, real world and late phase research at Quintiles, said: “Stella's experience developing innovative risk management solutions is a tremendous addition to our team. ... She said: “Together with my colleagues at Quintiles, I aim

More from appointments
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 2 fully matching, plus 19 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Consulting at McCann Health

We are the strategic consultancy of McCann Health. We combine fresh and creative thinking with scientific and strategic depth...

Latest intelligence

Webinar: Usability and UX: You’ve been asked to test...What next?
Thursday 27th June 2019 10am EDT / 3pm BST / 4pm CEST...
Event: EphMRA Annual Conference
We're sponsoring, exhibiting and presenting three papers at this year’s EphMRA Annual Conference in Warsaw, Poland....
Research Partnership and Janssen awarded runner-up in MR Excellence Awards
...

Infographics